TScan Therapeutics(TCRX) - 2021 Q4 - Annual Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 TSCAN THERAPEUTICS, INC. (Exact name of Registrant as specified in its Charter) (State or other jurisdiction of incorporation or organization) 830 Winter Street Waltham, Massachusetts 02451c (Address of principal executive offices) (Zip Code) Delaware 82-5282075 (I.R.S. Employer Identifi ...